Country: Ամերիկայի Միացյալ Նահանգներ
language: անգլերեն
source: NLM (National Library of Medicine)
FENTANYL (UNII: UF599785JZ) (FENTANYL - UNII:UF599785JZ)
Lake Erie Medical DBA Quality Care Products LLC
FENTANYL
FENTANYL 12 ug in 1 h
TRANSDERMAL
PRESCRIPTION DRUG
Fentanyl transdermal system is a transdermal formulation of fentanyl indicated for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients 2 years of age and older when a continuous, around-the-clock opioid analgesic is required for an extended period of time, and the patient cannot be managed by other means such as non-steroidal analgesics, opioid combination products, or immediate-release opioids. Patients considered opioid-tolerant are those who are taking at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily, or an equianalgesic dose of another opioid for a week or longer. Fentanyl transdermal system is contraindicated in the following patients and situations due to the risk of fatal respiratory depression: Fentanyl transdermal system is also contraindicated: Pregnancy C: There are no adequate and well-controlled studies in pregnant women. Fentanyl transdermal system should be used during pregnancy only
Fentanyl transdermal system is supplied in cartons containing 5 individually packaged systems. See chart for information regarding individual systems. Fentanyl Transdermal System Dose (mcg/hr) System Size (cm2 ) Fentanyl Content (mg) NDC Number Fentanyl Transdermal System - 12* 3.13 1.28 0378-9119-98 Fentanyl Transdermal System - 25 6.25 2.55 0378-9121-98 Fentanyl Transdermal System - 50 12.5 5.10 0378-9122-98 Fentanyl Transdermal System - 75 18.75 7.65 0378-9123-98 Fentanyl Transdermal System - 100 25 10.20 0378-9124-98 Store in original unopened pouch. Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]
Abbreviated New Drug Application
Lake Erie Medical DBA Quality Care Products LLC ---------- MEDICATION GUIDE Fentanyl Transdermal System, CII (fen’ ta nil) Issue: 7/2012 Fentanyl Transdermal System is: •A strong prescription pain medicine that contains an opioid (narcotic) that is used to treat moderate to severe around- the-clock pain, in people who are already regularly using opioid pain medicine. Important information about Fentanyl Transdermal System: •Get emergency help right away if you use too much fentanyl transdermal system (overdose). Fentanyl transdermal system overdose can cause life threatening breathing problems that can lead to death.•Never give anyone else your fentanyl transdermal system. They could die from using it. Store fentanyl transdermal system away from children and in a safe place to prevent stealing or abuse. Selling or giving away fentanyl transdermal system is against the law. Do not use fentanyl transdermal system if you have: •severe asthma, trouble breathing, or other lung problems.•a bowel blockage or have narrowing of the stomach or intestines. Before applying fentanyl transdermal system, tell your healthcare provider if you have a history of: •head injury, seizures •liver, kidney, thyroid problems•proble ms urinating •pancreas or gallbladder problems•abuse of street or prescription drugs, alcohol addiction, or mental health problems. Tell your healthcare provider if you: •have a fever•are pregnant or planning to become pregnant. Fentanyl transdermal system may harm your unborn baby.•are breastfeeding. Fentanyl passes into breast milk and may harm your baby.•are taking prescription or over-the-counter medicines, vitamins, or herbal supplements. When using fentanyl transdermal system: •Do not change your dose. Apply fentanyl transdermal system exactly as prescribed by your healthcare provider.•See the detailed Instructions for Use for information about how to apply and dispose of the fentanyl transdermal system.•Do not wear more than 1 patch at the same time unless your healthc read_full_document
FENTANYL- FENTANYL PATCH LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE FENTANYL TRANSDERMAL SYSTEM SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR FENTANYL TRANSDERMAL SYSTEM. FENTANYL TRANSDERMAL SYSTEM FOR TRANSDERMAL ADMINISTRATION, CII INITIAL U.S. APPROVAL: 1968 WARNING: ABUSE POTENTIAL, RESPIRATORY DEPRESSION AND DEATH, ACCIDENTAL EXPOSURE, CYTOCHROME P450 3A4 INTERACTION, AND EXPOSURE TO HEAT _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING_. • • • • • RECENT MAJOR CHANGES Boxed Warning 7/2012 Indications and Usage (1) 7/2012 Dosage and Administration (2) 7/2012 Contraindications (4) 7/2012 Warnings and Precautions (5) 7/2012 INDICATIONS AND USAGE • • • DOSAGE AND ADMINISTRATION • • • • • • • DOSAGE FORMS AND STRENGTHS • CONTRAINDICATIONS CONTAINS A HIGH CONCENTRATION OF FENTANYL, A SCHEDULE II CONTROLLED SUBSTANCE, WHICH IS SUBJECT TO MISUSE, ABUSE, ADDICTION, AND CRIMINAL DIVERSION. (9) FATAL RESPIRATORY DEPRESSION COULD OCCUR IN PATIENTS WHO ARE NOT OPIOID-TOLERANT AND IN PATIENTS THAT ARE OPIOID-TOLERANT EVEN IF FENTANYL TRANSDERMAL SYSTEM IS NOT MISUSED OR ABUSED. (5) ACCIDENTAL EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM, ESPECIALLY IN CHILDREN, CAN RESULT IN A FATAL OVERDOSE OF FENTANYL. (5) CYP3A4 INHIBITORS CAN RESULT IN A FATAL OVERDOSE OF FENTANYL FROM FENTANYL TRANSDERMAL SYSTEM. (5) AVOID EXPOSING THE FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES. TEMPERATURE DEPENDENT INCREASES IN FENTANYL RELEASE FROM THE SYSTEM MAY RESULT IN OVERDOSE AND DEATH. (5) Fentanyl transdermal system contains fentanyl, a full opioid agonist. Fentanyl transdermal system is indicated for the management of persistent, moderate to severe chronic pain in OPIOID-TOLERANT patients 2 years of age and older when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. (1) F read_full_document